1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. / Stahel, R; Thatcher, N; Früh, M; Le Péchoux, C; Postmus, P E; Sorensen, J B; Felip, E; Panel members.

In: Annals of Oncology, Vol. 22, No. 9, 2011, p. 1973-80.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Stahel, R, Thatcher, N, Früh, M, Le Péchoux, C, Postmus, PE, Sorensen, JB, Felip, E & Panel members 2011, '1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer', Annals of Oncology, vol. 22, no. 9, pp. 1973-80. https://doi.org/10.1093/annonc/mdr313

APA

Stahel, R., Thatcher, N., Früh, M., Le Péchoux, C., Postmus, P. E., Sorensen, J. B., Felip, E., & Panel members (2011). 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. Annals of Oncology, 22(9), 1973-80. https://doi.org/10.1093/annonc/mdr313

Vancouver

Stahel R, Thatcher N, Früh M, Le Péchoux C, Postmus PE, Sorensen JB et al. 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. Annals of Oncology. 2011;22(9):1973-80. https://doi.org/10.1093/annonc/mdr313

Author

Stahel, R ; Thatcher, N ; Früh, M ; Le Péchoux, C ; Postmus, P E ; Sorensen, J B ; Felip, E ; Panel members. / 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer. In: Annals of Oncology. 2011 ; Vol. 22, No. 9. pp. 1973-80.

Bibtex

@article{39aa59b3847c417c88d938443f2b2431,
title = "1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer",
abstract = "The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.",
author = "R Stahel and N Thatcher and M Fr{\"u}h and {Le P{\'e}choux}, C and Postmus, {P E} and Sorensen, {J B} and E Felip and S{\o}rensen, {Jens Benn}",
year = "2011",
doi = "http://dx.doi.org/10.1093/annonc/mdr313",
language = "English",
volume = "22",
pages = "1973--80",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

AU - Stahel, R

AU - Thatcher, N

AU - Früh, M

AU - Le Péchoux, C

AU - Postmus, P E

AU - Sorensen, J B

AU - Felip, E

AU - Panel members

PY - 2011

Y1 - 2011

N2 - The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

AB - The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

U2 - http://dx.doi.org/10.1093/annonc/mdr313

DO - http://dx.doi.org/10.1093/annonc/mdr313

M3 - Journal article

VL - 22

SP - 1973

EP - 1980

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -

ID: 40197770